9989 — Shenzhen Hepalink Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMid CapValue Trap
- HK$6.57bn
- HK$10.27bn
- CNY7.16bn
- 33
- 72
- 38
- 44
Annual cashflow statement for Shenzhen Hepalink Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -1,080 | -1,106 | -1,161 | -1,304 | -1,533 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 636 | -228 | 37.3 | -6.63 | -757 |
| Capital Expenditures | -535 | -362 | -212 | -194 | -222 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2,371 | 364 | -1,961 | 914 | 472 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1,836 | 1.7 | -2,174 | 720 | 250 |
| Financing Cash Flow Items | -1,152 | -1,196 | 3,635 | -51.8 | -139 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,696 | -234 | 2,506 | -501 | 330 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 796 | -450 | 254 | 149 | -160 |